Ganglioneuroma overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:


==Classification==
==Classification==
According to International Neuroblastoma Pathology Classification (INPC), ganglioneuroma may be classified into two subtypes/groups: Ganglioneuroma-maturing and ganglioneuroma-mature.<ref name="pmid19530234">{{cite journal| author=Okamatsu C, London WB, Naranjo A, Hogarty MD, Gastier-Foster JM, Look AT et al.| title=Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG. | journal=Pediatr Blood Cancer | year= 2009 | volume= 53 | issue= 4 | pages= 563-9 | pmid=19530234 | doi=10.1002/pbc.22106 | pmc=PMC2730988 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19530234  }} </ref>


==Pathophysiology==
==Pathophysiology==

Revision as of 18:03, 11 September 2015

Ganglioneuroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ganglioneuroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ganglioneuroma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ganglioneuroma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ganglioneuroma overview

CDC on Ganglioneuroma overview

Ganglioneuroma overview in the news

Blogs on Ganglioneuroma overview

Directions to Hospitals Treating Ganglioneuroma

Risk calculators and risk factors for Ganglioneuroma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Classification

According to International Neuroblastoma Pathology Classification (INPC), ganglioneuroma may be classified into two subtypes/groups: Ganglioneuroma-maturing and ganglioneuroma-mature.[1]

Pathophysiology

Causes

Differentiating brain tumors from other diseases

Epidemiology and Demographics

Risk factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other imaging findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

References

  1. Okamatsu C, London WB, Naranjo A, Hogarty MD, Gastier-Foster JM, Look AT; et al. (2009). "Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG". Pediatr Blood Cancer. 53 (4): 563–9. doi:10.1002/pbc.22106. PMC 2730988. PMID 19530234.


Template:WikiDoc Sources